Company & Sponsor Intelligence

Janssen Korea, Ltd., Korea

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting0

Completed4

Countries1

Therapeutic footprint

adhdalzheimersepilepsypain_neuropathy

Indexed studies

NCT01682681An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy
epilepsy · COMPLETED

NCT01819805A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen
pain_neuropathy · South KoreaCOMPLETED

NCT01734395A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease
alzheimers · COMPLETED

NCT01012622An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
adhd · PHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →